{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:58:16Z","timestamp":1792432696293,"version":"4.5.0"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,27]]},"DOI":"10.18632\/oncotarget.5413","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T01:26:06Z","timestamp":1445217966000},"page":"34846-34858","source":"Crossref","is-referenced-by-count":33,"title":["Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells"],"prefix":"10.18632","volume":"6","author":[{"given":"Sandeep S.","family":"Negi","sequence":"first","affiliation":[{"name":"Department of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(01)00650-9","article-title":"Directed proteomic analysis of the human nucleolus","volume":"12","author":"Lamond","year":"2002","journal-title":"Curr Biol"},{"key":"2","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1091\/mbc.e02-05-0271","article-title":"Functional proteomic analysis of human nucleolus","volume":"13","author":"Diaz","year":"2002","journal-title":"Mol Biol Cell"},{"key":"3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrm2184","article-title":"The multifunctional nucleolus","volume":"8","author":"Lamond","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/nucl.32235","article-title":"Nucleolar stress with and without p53","volume":"5","author":"DiMario","year":"2014","journal-title":"Nucleus"},{"key":"5","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1093\/emboj\/cdg579","article-title":"Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses","volume":"22","author":"Milner","year":"2003","journal-title":"Embo j"},{"key":"6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm1551","article-title":"RNA polymerases I and III, growth control and cancer","volume":"6","author":"White","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07449","article-title":"Suppression of myc oncogenic activity by ribosomal protein haploinsufficiency","volume":"456","author":"Ruggero","year":"2008","journal-title":"Nature"},{"key":"8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"Felsher","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/bjc.2011.241","article-title":"Oncogenic AKTivation of translation as a therapeutic target","volume":"105","author":"Ruggero","year":"2011","journal-title":"Br J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","article-title":"Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53","volume":"22","author":"Bliesath","year":"2012","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"pe38","DOI":"10.1126\/scisignal.2003477","article-title":"Revisiting the nucleolus: From marker to dynamic integrator of cancer signaling","volume":"5","author":"Ruggero","year":"2012","journal-title":"Sci Signal"},{"key":"12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/14728222.2013.818658","article-title":"Targeting RNA polymerase I transcription and the nucleolus for cancer therapy","volume":"17","author":"Pearson","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2013.12.009","article-title":"A targeting modality for destruction of RNA polymerase I that possesses anticancer activity","volume":"25","author":"Laiho","year":"2014","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/1535-7163.MCT-14-0256","article-title":"Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress","volume":"13","author":"Laiho","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.18632\/oncotarget.2020","article-title":"DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response","volume":"5","author":"Laiho","year":"2014","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics","volume":"3","author":"Proffitt","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Sanij","year":"2011","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"e12996","DOI":"10.1371\/journal.pone.0012996","article-title":"Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents","volume":"5","author":"Laiho","year":"2010","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.18632\/oncotarget.4093","article-title":"rRNA synthesis inhibitor, CX-5461, activates ATM\/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis","volume":"6","author":"Brown","year":"2015","journal-title":"Oncotarget"},{"key":"20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2008.11.001","article-title":"Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis","volume":"14","author":"Sawyers","year":"2008","journal-title":"Cancer Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1182\/blood-2007-10-113969","article-title":"Acute dasatinib exposure commits bcr-abl-dependent cells to apoptosis","volume":"114","author":"Deininger","year":"2009","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/2159-8290.CD-13-0611","article-title":"Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling","volume":"4","author":"Chandarlapaty","year":"2014","journal-title":"Cancer Discov"},{"key":"23","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","article-title":"The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01","volume":"275","author":"Piwnica-Worms","year":"2000","journal-title":"J Biol Chem"},{"key":"24","first-page":"5843","article-title":"Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells","volume":"61","author":"Pieper","year":"2001","journal-title":"Cancer Res"},{"key":"25","first-page":"791","article-title":"Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor","volume":"2","author":"Eastman","year":"1996","journal-title":"Clin Cancer Res"},{"key":"26","first-page":"2108","article-title":"The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1","volume":"60","author":"Sarkaria","year":"2000","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/1078-0432.CCR-06-2793","article-title":"Targeting checkpoint kinase 1 in cancer therapeutics","volume":"13","author":"Schwartz","year":"2007","journal-title":"Clin Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1200\/JCO.2007.14.9260","article-title":"Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia","volume":"26","author":"Deininger","year":"2008","journal-title":"J Clin Oncol"},{"key":"29","first-page":"5987","article-title":"Short exposure to actinomycin D induces \u201creversible\u201d translocation of protein B23 as well as \u201creversible\u201d inhibition of cell growth and RNA synthesis in HeLa cells","volume":"50","author":"Chan","year":"1990","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1091\/mbc.e12-12-0881","article-title":"The nucleolus stress response is coupled to an ATR-Chk1-mediated G2 arrest","volume":"24","author":"Pederson","year":"2013","journal-title":"Mol Biol Cell"},{"key":"31","doi-asserted-by":"crossref","first-page":"pe10","DOI":"10.1126\/stke.2242004pe10","article-title":"Sensing cellular stress: Another new function for the nucleolus?","volume":"2004","author":"Olson","year":"2004","journal-title":"Sci STKE"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.147","article-title":"Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate","author":"Derenzini","year":"2015","journal-title":"Oncogene"},{"key":"33","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1242\/jcs.086074","article-title":"Selective inhibition of rRNA transcription downregulates E2F-1: A new p53-independent mechanism linking cell growth to cell proliferation","volume":"124","author":"Derenzini","year":"2011","journal-title":"J Cell Sci"},{"key":"34","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1038\/onc.2010.279","article-title":"PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression","volume":"29","author":"Loreni","year":"2010","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00418-005-0754-9","article-title":"The moving parts of the nucleolus","volume":"123","author":"Dundr","year":"2005","journal-title":"Histochem Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/MCB.25.4.1258-1271.2005","article-title":"Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function","volume":"25","author":"Quelle","year":"2005","journal-title":"Mol Cell Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/sj.onc.1205871","article-title":"Human p14(arf): An exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function","volume":"21","author":"Nouvian-Dooghe","year":"2002","journal-title":"Oncogene"},{"key":"38","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/sj.onc.1206303","article-title":"p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice","volume":"22","author":"Gazzeri","year":"2003","journal-title":"Oncogene"},{"key":"39","first-page":"5743","article-title":"UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1","volume":"62","author":"Pommier","year":"2002","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1158\/0008-5472.CAN-04-0841","article-title":"Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe","volume":"64","author":"Schwartz","year":"2004","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1667\/RR3253","article-title":"Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cells","volume":"162","author":"Goldberg","year":"2004","journal-title":"Radiat Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"15779","DOI":"10.1073\/pnas.0808480105","article-title":"Exploring RNA transcription and turnoverby using click chemistry","volume":"105","author":"Salic","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:26:28Z","timestamp":1653319588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":42,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,10,27]]}},"alternative-id":["5413","26472108"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5413","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}